Sofinnova Venture Partners X, L.P.

Sofinnova Venture Partners X, L.P. has an estimated net worth of $112 Million. This is based on reported shares across multiple companies, which include , Vera Therapeutics, Inc., Aerovate Therapeutics, Inc., Inozyme Pharma, Inc., Bolt Biotherapeutics, Inc., and Akouos, Inc..

2021 was Sofinnova Venture Partners X, L.P.'s most active year for acquiring shares with 7 total transactions. Sofinnova Venture Partners X, L.P.'s most active month to acquire stocks was the month of January. 2021 was Sofinnova Venture Partners X, L.P.'s most active year for disposing of shares, totalling 4 transactions. Sofinnova Venture Partners X, L.P.'s most active month to dispose stocks was the month of January. 2021 saw Sofinnova Venture Partners X, L.P. paying a total of $21,999,980.00 for 9,427,899 shares, this is the most they've acquired in one year. In 2020 Sofinnova Venture Partners X, L.P. cashed out on 42,575,697 shares for a total of $0.00, their largest year based on trade value.